Previous studies demonstrated that maintenance of steady-state myogenic tone requires Ca2+-dependent myosin phosphorylation. The present studies furthered these observations by examining temporal relationships among Ca2+, myosin phosphorylation and vessel diameter during acute increases in intraluminal pressure and norepinephrine stimulation. Rat cremaster muscle arterioles were cannulated and loaded with the Ca2+-sensitive indicator fura-2. The extent of myosin phosphorylation was measured using two-dimensional gel electrophoresis. Acute increases in intraluminal pressure caused a biphasic increase in intracellular Ca2+ ([Ca2+]i), characterized by a transient peak followed by a decline to a steady-state level which remained significantly higher than control values. Peak [Ca2+]i was significantly related to vessel distension and increased with the change in wall tension. Increased intraluminal pressure resulted in a monophasic increase in myosin phosphorylation that was significantly correlated with instantaneous wall tension. In general, norepinephrine induced larger [Ca2+]i transients and a biphasic myosin phosphorylation pattern. The results demonstrate: (a) major roles for Ca2+ and myosin phosphorylation in arteriolar myogenic and norepinephrine-induced responses; (b) that changes in Ca2+ and phosphorylation during a myogenic response are related to changes in wall tension, and (c) differences in Ca2+ and phosphorylation patterns between the two modes of contraction reflect possible differences in underlying signaling mechanisms. The data further emphasize that spontaneous arteriolar tone represents a state of maintained smooth muscle activation that requires increases in [Ca2+]i and myosin light-chain phosphorylation.

1.
Bayliss WM: On the local reaction of the arterial wall to changes in internal pressure. J Physiol 1902;28:220–231.
2.
Harder DR: Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res 1984;55:197–202.
3.
Davis MJ, Donovitz JA, Hood JD: Stretch-activated single-channel and whole currents in vascular smooth muscle cells. Am J Physiol 1992;262(Heart Circ Physiol 31):C1083–C1088.
4.
Davis MJ, Meininger GA, Zawieja DC: Stretch-induced increase in intracellular calcium of isolated vascular smooth muscle cells. Am J Physiol 1992;263(Heart Circ Physiol 32):H1292–H1299.
5.
Zou H, Ratz PH, Hill MA: Role of myosin phosphorylation and [Ca2+]i in myogenic reactivity and arteriolar tone. Am J Physiol 1995;269(Heart Circ Physiol 38):H1590–H1596.
6.
Johnson PC: The myogenic response; in Bohr DR, Somlyo AP, Sparks HV (eds): Handbook of Physiology. Bethesda, American Physiological Society, 1980, section 2: The Cardiovascular System, vol II: Vascular Smooth Muscle, pp 409–442.
7.
Davis MJ, Hill MA: Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999;79:387–423.
8.
Meininger GA, Zaweija DC, Falcone JC, Hill MA, Davey JP: Calcium measurement in isolated arterioles during myogenic and agonist stimulation. Am J Physiol 1991;261(Heart Circ Physiol 30):H950–H959.
9.
Askoy MO, Mras S, Kamm KE, Murphy RA: Ca2+, cAMP, and changes in myosin phosphorylation during contraction of smooth muscle. Am J Physiol 1983;245(Cell Physiol 14):C255–C270.
10.
Morgan JP, Morgan KG: Stimulus-specific patterns of intracellular calcium levels in smooth muscle of the ferret portal vein. J Physiol 1984;355:155–167.
11.
Hai C, Murphy RA: Cross-bridge phosphorylation and regulation of latch state in smooth muscle. Am J Physiol 1988;254(Cell Physiol 23):C99–C106.
12.
Murphy R: What is special about smooth muscle? The significance of covalent crossbridge regulation. FASEB J 1994;8:311–318.
13.
Walsh MP: Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 1994;72:919–936.
14.
McCarron JG, Crichton CA, Langton PD, MacKenzie A, Smith GL: Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries. J Physiol 1997;498:371–379.
15.
Somlyo AP, Somlyo AV: Signal transduction and regulation in smooth muscle. Nature 1994;372:231–236.
16.
Goodman AH: Un calibreur vidéo simple pour l’utilization en microscopie vidéo. Innov Technol Biol Med 1990;9:350–356.
17.
Ratz PH: High α1-adrenoceptor occupancy decreases relaxing potency of nifedipine by increasing myosin light chain phosphorylation. Circ Res 1993;72:1308–1316.
18.
Hill MA, Simpson BE, Meininger GA: Altered cremaster muscle hemodynamics due to disruption of the deferential feed vessels. Microvasc Res 1990;39:349–363.
19.
D’Angelo G, Davis MJ, Meininger GA: Calcium and mechanotransduction of the myogenic response. Am J Physiol 1997;273(Heart Circ Physiol 42):H175–H182.
20.
Herlihy JT, Murphy RA: Length-tension relationship of smooth muscle of the hog carotid artery. Circ Res 1973;33:275–283.
21.
Hill MA, Zou H, Davis MJ, Potocnik S, Price S: Transient increases in diameter and [Ca2+]i following acute pressure increases are not obligatory for myogenic constriction. Am J Physiol 2000;278:H345–H352.
22.
Brayden JE, Nelson MT: Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992;256:532–535.
23.
Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ: Relaxation of arterial smooth muscle by calcium sparks. Science 1995;270:633–637.
24.
Kitazawa T, Masuo M, Somlyo AP: G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 1991;88:9307–9310.
25.
Zou H, Ratz PH, Hill MA: [Ca2+]i in arteriolar myogenic and agonist-induced tone. FASEB J 1996;10:A57.
26.
VanBavel E, Wesselman JPM, Spaan JAE: Myogenic activation and calcium sensitivity of cannulated rat mesenteric small arteries. Circ Res 1998;82:210–220.
27.
Hill MA, Davis MJ, Song J, Zou H: Calcium dependence of indolactam-mediated contractions in resistance vessels. J Pharmacol Exp Ther 1996;276:867–874.
28.
Kitazawa T, Kobayashi S, Horiuti K, Somlyo AV, Somlyo AP: Receptor-coupled, permeabilized smooth muscle: Role of the phosphatidylinositol cascade, G-proteins, and modulation of the contractile response to Ca2+. J Biol Chem 1989;264:5339–5342.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.